Eton Pharmaceuticals, Inc. (ETON) stock analysis
ETON · Eton Pharmaceuticals, Inc.
Latest recorded price: USD 63.88
Model-estimated fair value: USD 1.85. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
At $63.88, ETON trades 3,356.1% above the model's base-case value of $1.85. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $1.65 in the conservative case and $2.11 in the optimistic case, with a valuation confidence score of 9/100. Fiscal 2025 figures: revenue growth 55.5%, free cash flow margin 12.7%. The model flags 1 risk signal for this company (1 high severity).
Similar companies in Healthcare
- Hims & Hers Health, Inc. (HIMS)
- Harrow, Inc. (HROW)
- Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)
- Lantheus Holdings, Inc. (LNTH)
- Liquidia Corporation (LQDA)
- Neurocrine Biosciences, Inc. - Common Stock (NBIX)
- Phibro Animal Health Corporation (PAHC)
- Prestige Consumer Healthcare Inc. (PBH)